Introduction
============

Several indices exist to monitor adequate oxygenation, but no such index exists for ventilatory efficiency. The ventilatory ratio (VR) is a simple tool to monitor changes in ventilatory efficiency using variables commonly measured at the bedside \[[@B1]\]:

$$\text{VR}\, = \,\frac{{\overset{˙}{V}}_{E_{measured}} \times P_{a_{co_{2\, measured}}}\,}{{\overset{˙}{V}}_{E_{predicted}} \times P_{a_{co_{2\, predicted}}}\,}$$

See Figure [1](#F1){ref-type="fig"} overleaf (where predicted values are VE 100 ml/kg/minute and PaCO~2~5 kPa).

![**Chi-squared test for trends *P*= 0.0015**.](cc9599-1){#F1}

Methods
=======

The Nottingham Physiology Simulator (NPS), a validated computational model of cardiopulmonary physiology \[[@B2]\], was used to validate the ability of VR to reflect ventilatory efficiency *ex vivo*. Three virtual patients were configured, representing healthy lung, ARDS and COPD. VR was calculated while minute ventilation, ventilation rate and VCO~2~were each varied in isolation. The clinical uses of VR were then examined in a database comprising 122 patients with ALI and ARDS \[[@B3]\]. Standard respiratory data and VR values were analysed in all patients.

Results
=======

The NPS model showed significant correlation between VR and physiological deadspace fraction (Vd/Vtphys) at constant VCO~2~(*P*\< 0.001, *r*= 0.99). Similarly, VCO~2~had a linear relationship with VR at constant Vd/Vtphys. Across the various ventilatory configurations the median values and ranges of calculated VR for the three patients were as follows: normal patient VR 0.89 (0.61 to 1.36), COPD 1.36 (0.95 to 1.89) and ARDS 1.73 (1.2 to 2.62). In the ALI/ARDS database the range of values for VR was 0.56 to 3.93 (median 1.36). Patients with ARDS had a significantly higher VR in comparison with patients with ALI (1.44, 1.25 to 1.77 vs. 1.25, 0.94 to 1.6, *P*= 0.02). VR was significantly higher in nonsurvivors as compared with survivors (1.7 ± 0.64 vs. 1.45 ± 0.56, *P*\< 0.03). There was poor correlation between PaO~2~/FiO~2~ratio and VR in the population (*r*= -0.32, 95% CI = -0.47 to -0.15).

Conclusions
===========

*Ex vivo*modling shows that VR can be simply and reliably used to monitor ventilatory efficiency at the bedside. VR is influenced by changing CO~2~production and deadspace ventilation. As a clinical tool it is a predictor of outcome and is independent to PaO~2~/FiO~2~ratio.
